CareDx Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
John Hanna
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | less than a year |
Board average tenure | 9.8yrs |
Recent management updates
Recent updates
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26%
Nov 05CareDx Resolves Key Issues: Poised For Growth In Transplant Diagnostics
Sep 29CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Aug 01CareDx: Benefiting From Some Certainty
Jul 15Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge
Apr 27CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too
Mar 02CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry
Dec 27CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Dec 27Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price
Jun 29Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)
May 16CareDx: Shaking Off First-Mover Disadvantage
Oct 18CareDx: Best Near Cap-Gain Health Diagnostics Prospect Say Market Makers
Aug 08CEO
John Hanna (44 yo)
less than a year
Tenure
Mr. John Walter Hanna, Jr. is President, Chief Executive Officer & Director of CareDx, Inc since April 15, 2024. He served as General Manager of Endocrinology, Breast Cancer and Lymphoma at Veracyte, Inc....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CFO & Principal Accounting Officer | 2.6yrs | US$3.09m | 0.091% $ 1.0m | |
Executive Director | 3.1yrs | US$354.93k | 0.50% $ 5.5m | |
President | less than a year | no data | no data | |
Chief Operating Officer | less than a year | no data | no data | |
Chief Scientific Officer | 1.3yrs | no data | no data | |
General Counsel & Secretary | less than a year | no data | 0.21% $ 2.3m | |
Senior VP & Head of Human Resources | 1.9yrs | no data | no data | |
Head of Software Engineering | no data | no data | no data | |
Chief Strategy Officer | less than a year | no data | no data | |
Chief Commercial Officer | less than a year | no data | no data | |
Chief Data & Artificial Intelligence Officer | less than a year | no data | no data |
1.0yrs
Average Tenure
48yo
Average Age
Experienced Management: CDNA's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Director | 12.1yrs | US$354.93k | 0.50% $ 5.5m | |
President | less than a year | no data | no data | |
Independent Director | 21.9yrs | US$355.87k | 0.21% $ 2.3m | |
Independent Chairman | 13.1yrs | US$456.03k | 0.21% $ 2.3m | |
Independent Director | 5.3yrs | US$384.45k | 0.045% $ 501.4k | |
Independent Director | 9.8yrs | US$360.87k | 0.046% $ 506.3k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Independent Director | 10.7yrs | US$368.74k | 0.21% $ 2.3m | |
Independent Director | less than a year | no data | no data | |
Independent Director | 3.3yrs | US$353.74k | 0.013% $ 143.6k |
9.8yrs
Average Tenure
67.5yo
Average Age
Experienced Board: CDNA's board of directors are considered experienced (9.8 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 10:51 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CareDx, Inc is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Mark Massaro | BTIG |
William Bonello | Craig-Hallum Capital Group LLC |
Matthew Sykes | Goldman Sachs |